Acquired by Agilent Technologies.
Multiplicom was created in 2011 as a spin-off of the University of Antwerp and VIB. Multiplicom develops, manufactures and commercializes leading-edge and easy-to-use genetic test kits based on the latest molecular diagnostic technologies. Multiplicom produces molecular diagnostic kits that enable clinical laboratories to perform affordable testing for personalized medicine.
Acquired by Agilent Technologies.
Axithra is developing new technology for accurate drug concentrations in blood.
Flindr aims to restore a patient’s impaired immune response to cancer
QustomDot is developing cadmium-free quantum dots that are stable enough for advanced applications.
